Author name: TB Alliance

The latest in a series of announcements this year, Lupin Limited, Inc., an Indian pharmaceutical and a TB Alliance Stakeholder,

Dr. Christopher Lipinski, member of the TB Alliance Scientific Advisory Committee and a retired Senior Research Fellow at Pfizer Global

“Public-private partnerships have adopted business models that exploit the venture capital approach to investment in new product R&D…The commitment of

American Society for Microbiology 44th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) (Washington, DC, Oct 31, 2004) The

Enlisting government participation and commitment to new drugs is at the core of the TB Alliance’s design as a public-private

TB Alliance is teaming up with the newly launched European and Developing Countries Clinical Trials Partnership (EDCTP) to enhance clinical

A lead compound in the TB Alliance portfolio, PA-824, recently showed additional promise as a potential TB drug in studies

From The New York Times – July 16, 2004By Lawrence K. Altman BANGKOK, July 15 – Nelson Mandela came to

From Reuters – July 15, 2004 BANGKOK (Reuters) – The global war on AIDS could be lost if the world